Trademark: 79283146
Word
SUMITOVANT BIOPHARMA
Status Date
Tuesday, November 23, 2021
Registration Number
6564625
Registration Date
Tuesday, November 23, 2021
Filing Date
Friday, December 27, 2019
Published for Opposition
Tuesday, September 7, 2021
9 Calculating machines; data processing apparatus; computers; computer hardware; computer peripherals; Downloadable computer software for providing, analyzing and generating reports; downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest; downloadable computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information; downloadable computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software for analytics in the fields of public health, healthcare, biomedical research; downloadable computer software for analytics for clinical trial data
5 Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterological system, and ophthalmologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapy; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for hereditary diseases; pharmaceutical diagnostic preparations for medical purposes; pharmaceutical diagnostic reagents for medical use; biologic preparations for medical and therapeutic purposes, namely, vaccines; biologic preparations for medical and therapeutic purposes, namely, cells for medical or clinical use; biologic preparations for medical and therapeutic purposes, namely, nucleic acid sequences for medical purposes
35 Advertising; publicity agency services; business management; business management assistance; business administration; business consulting services; secretarial services; providing office functions; business research; providing business information; marketing research; market analysis services; provision of market research information; marketing services; compiling of information into computer databases; updating and maintenance of data in computer databases; business data analysis; assistance, advisory services and consultancy with regard to business analysis, in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis; statistical analysis and reporting in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis and reporting services for business purposes in the fields of healthcare data, biomedical and pharmaceutical research and clinical trial data; business analysis in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; systematization of data in computer databases
44 Provision of medical information; providing health information; providing medical information from a web site; providing healthcare information from a web site; health counseling; provision of medical information relating to pharmaceutical and biologic therapeutic products
42 technical consultancy relating to technical and scientific analysis in the fields of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; medical research; chemistry services, namely, research in the field of chemistry; clinical trials, namely, conducting clinical trials for others; analysis of technical data, namely, data analytics in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; testing, inspection or scientific research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information relating to clinical trials of pharmaceuticals; medical and scientific research in the field of pharmaceutical and biologic therapeutic products; providing information relating to testing, inspection or medical and scientific research of pharmaceuticals; cloud computing featuring software for use in database management in the field of healthcare, pharmaceuticals, biomedicine, clinical trial, post-market trial data; provision of scientific and technological information and data relating to scientific and technological research and development in the fields of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; rental of computers; providing temporary use of online non-downloadable computer programs on data networks containing databases of pharmaceutical products, medical information, clinical trial data as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; software as a service [SaaS] featuring software for providing information online in the fields of biomedical research and clinical trials from a computer database or the Internet; computer software design, computer programming, and maintenance of computer software
The wording "SUMITOVANT" has no meaning in a foreign language.
"BIOPHARMA"
Sep 9, 2022
Change Of Name/Address Rec'd From Ib
May 30, 2022
Final Decision Transaction Processed By Ib
May 10, 2022
Final Disposition Notice Sent To Ib
May 10, 2022
Final Disposition Processed
Feb 23, 2022
Final Disposition Notice Created, To Be Sent To Ib
Nov 23, 2021
Registered-Principal Register
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Sep 5, 2021
Notification Processed By Ib
Aug 18, 2021
Notification Of Possible Opposition Sent To Ib
Aug 18, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Jul 30, 2021
Approved For Pub - Principal Register
Jul 30, 2021
Examiner's Amendment Entered
Jul 30, 2021
Notification Of Examiners Amendment E-Mailed
Jul 30, 2021
Examiners Amendment E-Mailed
Jul 30, 2021
Examiners Amendment -Written
Jul 13, 2021
Teas/Email Correspondence Entered
Jul 13, 2021
Correspondence Received In Law Office
Jul 13, 2021
Teas Request For Reconsideration Received
Mar 10, 2021
Notification Of Final Refusal Emailed
Mar 10, 2021
Final Refusal E-Mailed
Mar 10, 2021
Final Refusal Written
Feb 3, 2021
Teas/Email Correspondence Entered
Feb 3, 2021
Correspondence Received In Law Office
Feb 3, 2021
Assigned To Lie
Oct 27, 2020
Teas Response To Office Action Received
Jul 8, 2020
Attorney Review Completed
Jul 1, 2020
Correction From Ib Entered - Attorney Review Required
Jun 26, 2020
Correction Transaction Received From Ib
May 15, 2020
Refusal Processed By Ib
Apr 28, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Apr 28, 2020
Refusal Processed By Mpu
Apr 17, 2020
Application Filing Receipt Mailed
Apr 15, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Apr 14, 2020
Non-Final Action Written
Apr 13, 2020
Assigned To Examiner
Apr 13, 2020
New Application Office Supplied Data Entered In Tram
Apr 9, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
